Alzheimer's Drugs: Little Benefit, Big Risks
Anti-amyloid Alzheimer's drugs show limited benefit & increased risks of brain swelling/bleeding. Re-evaluating treatment efficacy is crucial.
04 May 2026
Anti-amyloid Alzheimer's drugs show limited benefit & increased risks of brain swelling/bleeding. Re-evaluating treatment efficacy is crucial.
GLP-1 drugs are being explored for longevity, but current evidence does not definitively prove their efficacy for life extension in healthy individuals.
